Latest Breaking News On - Lupus nephritis - Page 8 : comparemela.com

Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

ROCKVILLE, Md. & EDMONTON, Alberta, November 13, 2023 Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

United kingdomUnited statesPeter greenleafDrug administrationJapanese ministry of healthAurinia pharmaceuticalsAurinia pharmaceuticals incOtsuka pharmaceutical ltdJapanese ministryChief executive officerRed cell aplasiaDrug interactionsModerate hepatic impairmentPrescribing informationBoxed warningMedication guide

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kenneth kalunianMaple fungMichael mooreAmerican college of rheumatologyOno pharmaceutical co ltdLupus networkInvestor relations corporate communicationsEquillium incMedicines partnershipSchool of medicineExchange commissionMono pharmaceuticalsPeuropean league against rheumatismEuropean renal associationAmerican collegeOno pharmaceutical

Obinutuzumab Shown to Lower Kidney Complications, Steroid Use Among Individuals with Lupus Nephritis

This research into obinutuzumab may provide some hope for those facing the most common cause of kidney damage among patients with lupus.

United statesSan diegoRoss terresBrad rovinOhio state university wexner medical centerOhio state university brad rovinAmerican college of rheumatologyOhio state universityAmerican collegeLatin americaWexner medical centerRelated outcomesSteroid sparing effectsActive lupus nephritis treatedPost hoc analysisAccessed november

Antibody Proves as a Revolutionary Hope for Lupus Nephritis

Antibody Proves as a Revolutionary Hope for Lupus Nephritis
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.

Lupus nephritisKidney function

Clinical trial generates promising results for obinutuzumab in patients with lupus nephritis

Clinical trial generates promising results for obinutuzumab in patients with lupus nephritis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Brad rovinOhio state university wexner medical centerOhio state university wexner medicalKidney outcomesKidney function with obinutuzumabLupus nephritisPost hoc analysis